Project Grant R01HD111415
- Project Grant Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $123,349 Project Grant awarded August 1, 2025, by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The two-year award, with completion scheduled for July 31, 2027, supports research investigating convergent mechanisms of respiratory dysregulation following seizures...
- Federal Grant Award Summary Boston Children's Hospital received a $705,715 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective February 1, 2026, through December 31, 2030. The award funds a multiomic investigation into sudden unexplained pediatric deaths (SUDP), including Sudden Infant Death Syndrome (SIDS) and Sudden Unexplained Death in...
- Grant Award Summary The Medical College of Wisconsin, Inc. received a $964,960 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 15, 2025, with a completion date of May 31, 2030. The award funds research investigating pulmonary vagal sensory neurons (PSNs) and their role in dysfunctional neural control of breathing in chronic lung disease, specifically bronchopulmonary dysplasia (BPD),...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Children's Research Institute a $227,500 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025 through July 31, 2027. This pre-clinical research project delivers investigative services focused on protecting thalamic neurons that regulate consciousness following cardiac arrest. The research employs...
- SMILE (Sickle Cell Disease Microbiologic and Immunologic Links to Health) - Respiratory Control Research Project Grant Emory University received a $794,661 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), with an award date of September 19, 2025, and a completion date of June 30, 2030. This research initiative investigates how higher-order brain regions interact with brainstem circuits to produce...
- Federal Grant Award Summary The Children's Research Institute received a $500,500 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 1, 2025, through May 31, 2027. The award funds the development of quantitative electroencephalogram (EEG) biomarkers for Smith-Magenis Syndrome (SMS), a rare neurodevelopmental disorder caused by deletion or mutation of the...
- Grant Award Summary The College of William & Mary received a $234,375 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded February 1, 2026, with completion targeted for January 31, 2028. This research grant supports basic neuroscience investigation into the monosynaptic connections between the amygdala and prebotzinger complex (PreBötC), the...
- Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $106,474 to the Regents of the University of Michigan on September 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to support a K99/R00 Pathway to Independence award focused on investigating the role of endogenous opioids in respiratory development. The research will deliver scientific findings on how opioid signaling influences the development and physiology of brainstem respiratory...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $219,483 Project Grant to the University of Texas Southwestern Medical Center effective June 16, 2026, through May 31, 2031, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). Dr. Ethan Sanford, a pediatric critical care physician and anesthesiologist, will conduct a multicenter prospective analysis of cerebral autoregulation...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the Regents of the University of California, San Francisco a Project Grant of $673,512 under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, with completion targeted for April 30, 2029. This research project investigates the neural mechanisms underlying unconscious breathing regulation, specifically examining whether breathing rhythm originates from a reciprocal...
CENTRAL & PERIPHERAL MECHANISMS OF RESPIRATORY & AUTONOMIC CONTROL DYSFUNCTION IN A NOVEL MODEL OF SIDS: PREDICTIVE BIOMARKERS AND THE ROLE OF THE EXTRACELLULAR MATRIX - PROJECT SUMMARY THE TRIPLE RISK MODEL DESCRIBES SIDS OCCURRENCES WHEN AN INTRINSICALLY VULNERABLE INFANT EXPERIENCES AN EXOGENOUS INSULT RESULTING IN A CHRONICALLY HYPOXIC/HYPERCAPNIC ENVIRONMENT PARTICULARLY DURING A CRITICAL DEVELOPMENTAL PERIOD. SIDS PATHOPHYSIOLOGY INCLUDES EVIDENCE OF CHRONIC HYPOXIA EXPOSURE, BRAINSTEM GLIOSIS AND SEROTONERGIC ABNORMALITIES, AS WELL AS RESPIRATORY/AUTONOMIC DYSFUNCTION AND CAROTID BODY ABNORMALITIES. ALTHOUGH ANIMAL MODELS HAVE BEEN INSTRUMENTAL IN ADVANCING OUR UNDERSTANDING OF SIDS, THE LACK OF MODELS THAT RECAPITULATE THE HALLMARK FEATURES HAS HINDERED OUR ABILITY TO CONFIRM SIDS PATHOPHYSIOLOGY AND RESOLVE THE MAJOR HYPOTHETICAL/PROPOSED FEATURES. WE RESOLVED THIS HURDLE AFTER DISCOVERING A RAT MODEL THAT CLOSELY SIMULATES POSTNATAL HYPOXIA COMPONENT OF SIDS AS AN EXOGENOUS STRESSOR IN A VULNERABLE NEONATE. IN THIS MODEL, PROLONGED/SUSTAINED (DAYS) HYPOXIA EXPOSURE DURING A UNIQUELY CRITICAL PERIOD OF POSTNATAL DEVELOPMENT RESULTS IN SPONTANEOUS UNEXPLAINED DEATH SEVERAL DAYS LATER. IMPORTANTLY, IN BOTH PUBLISHED AND PRELIMINARY STUDIES (THIS PROPOSAL) THE MODEL RECAPITULATES ALL OF THE AFOREMENTIONED SIDS FEATURES. HERE, USING OUR NOVEL MODEL, WE PROPOSE THE NOVEL HYPOTHESIS THAT THE HALLMARK BRAINSTEM ABNORMALITIES (MICROGLIA AND 5-HT) IN SIDS IS IN RESPONSE TO CHRONIC DISRUPTION OF CAROTID BODY AFFERENT INPUTS INTO THE BRAINSTEM. WE PROPOSE THAT THESE DISRUPTED INPUTS OVER SEVERAL DAYS ARE SUFFICIENT TO ELICIT A LOCALIZED BRAINSTEM MICROGLIAL RESPONSE (AS SEEN IN SIDS), ULTIMATELY LEADING TO THE FATAL ABNORMALITIES IN BRAINSTEM NEUROCHEMISTRY IN KEY RESPIRATORY/AUTONOMIC CONTROL REGIONS. A PARTICULARLY NOVEL COMPONENT OF OUR PROPOSAL IS THE DISCOVERY OF A MICROGLIAL INHIBITOR, WHICH PREVENTS THE ADVERSE EFFECTS OF HYPOXIA EXPOSURE, THUS FOR THE FIRST TIME IN ANY SETTING, WE MAY BE ON THE PATH TO A PREVENTATIVE MEASURE AGAINST SIDS. WE ALSO PROPOSE THAT ABERRANT EXPRESSION OF SEVERAL COMPONENTS OF THE EXTRACELLULAR MATRIX MAY BE A NEW CENTRAL (BRAINSTEM) AND PERIPHERAL (CAROTID BODY) PATHOPHYSIOLOGICAL MECHANISM IN SIDS. FINALLY, GIVEN THE COMPELLING SIMILARITIES IN OUR MODEL WITH SIDS CASES, WE ARE POISED TO ASSESS SERUM AND URINE BIOMARKERS FOR IDENTIFIERS OF AT-RISK INFANTS AND PREDICTORS OF LATER MORTALITY. OVERALL, THIS PROPOSAL WILL: 1) BE FUNDAMENTAL TO OUR UNDERSTANDING OF RESPIRATORY AND AUTONOMIC DYSFUNCTION ASSOCIATED WITH SIDS, 2) PROVIDE A MECHANISTIC PERSPECTIVE ON THE ROOT CAUSE OF THE COMMON BRAINSTEM ABNORMALITIES, 3) DISCOVER POTENTIALLY NEW SIDS PATHOPHYSIOLOGY (PER THE REQUIREMENTS OF THE NOSI, AND 4) REVEAL A GLIMMER OF HOPE AT A PROPHYLACTIC TREATMENT TOWARD SIDS PREVENTION.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $561.3k | 6/9/26 | ||
| Not listed | $555.6k | 7/22/25 | ||
| Not listed | $571.2k | 7/31/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
RES603473S | President And Trustees Of Bates College | Project Grant R01HD111415 | $51.1k | 8/5/25 |